Hormone replacement therapy in postmenopausal women with end-stage renal disease

Kidney International

Volumn 57, Issue 1, 2000, Pages 341-342

  Andreoli, S P ^a  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

Artery disease; Atherosclerosis; Coronary; ESRD; Estrogen; Osteoporosis

Indexed keywords

ESTROGEN; PROGESTERONE;

BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; DEMENTIA; DEMOGRAPHY; DRUG SAFETY; EDITORIAL; ENDOMETRIUM HYPERPLASIA; ESTROGEN DEFICIENCY; HIP FRACTURE; HORMONE SUBSTITUTION; KIDNEY FAILURE; LIFE EXPECTANCY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; THROMBOEMBOLISM;

EID: 0034005904     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00850.x     Document Type: Editorial

References (15)

1. D. Grady S.M. Rubin D.B. Pettiti C.S. Fox D. Black B. Ettinnger V.L. Ernster S.R. Cummings Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Int Med 117 1992 1016 1037
2. T. Naessen I. Persson H.O. Adami R. Bergstrom L. Bergkvist Hormone replacement therapy and the risk for first fracture: A prospective, population based cohort study Ann Int Med 113 1990 95 103
3. K. Yaffe G. Sawaya I. Lieberburg D. Grady Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia JAMA 279 1990 688 695
4. Trial WGFTP Effect of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial JAMA 273 1995 199 208
5. T.L. Bush M.K. Whitemen Hormone replacement therapy and risk of breast cancer JAMA 281 1999 2140 2141
6. N.F. Santora N.F. Col M.H. Eckman J.B. Wong S.G. Pauker J.A. Cauley J. Amuda S. Crawford C.B. Johannes J.E. Rossouw C.N.B. Merz Hormone replacement therapy—Where are we going? J Clin Endrocrin Metabol 84 1999 1798 1802
7. F. Grodstein M.J. Stampfer S.Z. Goldhaber J.E. Manson G.A. Colditz F.E. Speizer W.C. Willett C.H. Hennekans Prospective study of exogenous hormone and risk of pulmonary embolism in women Lancet 348 1996 983 987 10.1016/s0140-6736(96)07308-4
8. A. Linder B. Charra D.J. Sheffard B.H. Scrib Accelerated atherosclerosis in prolonged maintenance hemodialysis N Engl J Med 290 1974 697 701
9. A.S. Levey Controlling the epidemic of cardiovascular disease in chronic renal failure: Where do we start? Am J Kidney Dis 32 Suppl 1998 S5 S13
10. V.L. Handa R. Landerman J.T. Hanlon T. Harris H.J. Cohen Do older women use estrogen replacement? Data from the Duke established populations for epidemiologic studies of the elderly J Am Geriatr Soc 44 1996 1 6
11. C.O. Stehman-Breen D. Gillen D. Gipson Prescription of hormone replacement therapy in postmenopausal women with renal failure Kidney Int 56 1999 2243 2247
12. J.L. Holly R.J. Schmidt F.H. Bender F. Dumler M. Schiff Gynecologic and reproductive issues in women on dialysis Am J Kidney Dis 29 1997 685 690
13. J.A. Beto V.K. Bansal Interventions for other risk factors: Tobacco, use, physical inactivity, menopause, and homocysteine Am J Kidney Dis 32 Suppl 1998 S172 S182
14. E.S. Ginsberg W.F. Owen L.M. Greenberg B.F. Shea J.M. Lazarus B.W. Walsh Estrogen absorption and metabolism in postmenopausal women with end-stage renal disease J Clin Endocrinol Metab 81 1998 4414 4417
15. S. Hulley D. Grady T. Bush C. Furberg D. Herrington B. Riggs E. Vittinghoff Randomized trail of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 1998 605 613